JPRN-UMIN000025269已完成未知
Japan PHarmacological Audit study of Safety and Efficacy in Real world (Phase-R) ESAS Study - Phase-R ESAS Study
The University of Tokyo, The Institute of Medical Science0 个研究点目标入组 400 人开始时间: 2016年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who cannot answer ESAS scoring due to consciousness disturbance or severe deterioration.
研究者
相似试验
已完成
不适用
Japan PHarmacological Audit study of Safety and Efficacy in Real worldCancerJPRN-UMIN000013326Department of Palliative Medicine, Osaka University Graduate School of Medicine850
已完成
不适用
Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium StudyJPRN-UMIN000018589The University of Tokyo, The Institute of Medical Science1,000
已完成
不适用
Japan PHarmacological Audit study of Safety and Efficacy in Real world (Phase-R) Nausea and Vomiting StudymalignancyJPRN-UMIN000020493The University of Tokyo, The Institute of Medical Science100
已完成
不适用
PHarmacological Audit study of Safety and Effectiveness in Real world: Naldemedine for Opioid-Induced Constipation studyopioid-induced constipationJPRN-UMIN000031381ational Cancer Center200
暂停
Unknown
PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Dyspnea in Patients with Non-malignant Respiratory Diseases Studyon-malignant respiratory diseasesJPRN-UMIN000049267ational Hospital Organization Kinki-Chuso Chest Medical Center200